Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Biomarin Pharmaceuticals (BMRN)

Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,889,804
  • Shares Outstanding, K 188,734
  • Annual Sales, $ 2,419 M
  • Annual Income, $ 167,650 K
  • 60-Month Beta 0.31
  • Price/Sales 6.91
  • Price/Cash Flow 50.35
  • Price/Book 3.43
Trade BMRN with:

Options Overview Details

View History
  • Implied Volatility 38.38% ( +1.01%)
  • Historical Volatility 15.27%
  • IV Percentile 84%
  • IV Rank 56.06%
  • IV High 50.90% on 06/28/23
  • IV Low 22.40% on 11/03/23
  • Put/Call Vol Ratio 0.98
  • Today's Volume 999
  • Volume Avg (30-Day) 1,863
  • Put/Call OI Ratio 0.80
  • Today's Open Interest 34,495
  • Open Int (30-Day) 52,042

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 0.37
  • Number of Estimates 10
  • High Estimate 0.41
  • Low Estimate 0.25
  • Prior Year 0.39
  • Growth Rate Est. (year over year) -5.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
84.70 +5.66%
on 03/25/24
93.36 -4.15%
on 04/15/24
+4.36 (+5.12%)
since 03/22/24
3-Month
83.44 +7.25%
on 03/15/24
94.51 -5.31%
on 01/23/24
-4.55 (-4.84%)
since 01/22/24
52-Week
76.02 +17.72%
on 11/02/23
99.56 -10.11%
on 12/14/23
-8.02 (-8.22%)
since 04/21/23

Most Recent Stories

More News
4 Extraordinary Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market

Although the Nasdaq Composite is galloping to record highs, amazing deals among growth stocks can still be uncovered.

COMP : 3.32 (+2.47%)
$NASX : 15,451.31 (+1.11%)
PYPL : 63.19 (+1.41%)
FVRR : 19.40 (-1.17%)
BMRN : 89.49 (+0.97%)
GOOGL : 156.28 (+1.42%)
GOOG : 157.95 (+1.43%)
BioMarin: Q4 Earnings Snapshot

BioMarin: Q4 Earnings Snapshot

BMRN : 89.49 (+0.97%)
3 No-Brainer Stocks to Buy With $200 Right Now

A reasonably small amount of money can go a long way when it's put to work in innovative, industry-leading businesses.

NEE : 65.31 (+1.57%)
BMRN : 89.49 (+0.97%)
PM : 94.06 (+0.31%)
New Era at Elliott: Appointing Partners to Spearhead Diverse Investments

Elliott Investment Management, the renowned activist investment firm founded by billionaire Paul Singer, is enhancing its leadership with the appointment of three new partners. In a strategic move, Elliott...

CCI : 95.08 (-0.13%)
PINS : 32.73 (+1.02%)
ETSY : 66.45 (-0.46%)
PSX : 157.05 (+1.51%)
GT : 11.89 (+0.08%)
BMRN : 89.49 (+0.97%)
STZ : 259.74 (-0.37%)
CRM : 273.81 (+1.27%)
CTXS : 103.90 (+0.04%)
4 Marvelous Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip

A greater than 7% decline in the Nasdaq Composite from its record high signals that opportunistic investors can still find bargains.

COMP : 3.32 (+2.47%)
$NASX : 15,451.31 (+1.11%)
MA : 456.75 (+0.30%)
BMRN : 89.49 (+0.97%)
ETSY : 66.45 (-0.46%)
META : 481.73 (+0.14%)
4 Preeminent Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip

An 11% decline in the Nasdaq Composite over the past two years is an open invitation for opportunistic growth investors to go shopping.

COMP : 3.32 (+2.47%)
$NASX : 15,451.31 (+1.11%)
NIO : 4.00 (+5.26%)
OKTA : 93.24 (+1.31%)
BMRN : 89.49 (+0.97%)
BIDU : 97.24 (+2.30%)
4 Unique Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip

A 19% decline in the Nasdaq Composite over the past two years represents an ideal time for opportunistic long-term investors to go shopping for bargains.

COMP : 3.32 (+2.47%)
$NASX : 15,451.31 (+1.11%)
GOOGL : 156.28 (+1.42%)
GOOG : 157.95 (+1.43%)
FSLY : 12.53 (+1.87%)
BMRN : 89.49 (+0.97%)
ETSY : 66.45 (-0.46%)
AMZN : 177.23 (+1.49%)
BioMarin: Q3 Earnings Snapshot

BioMarin: Q3 Earnings Snapshot

BMRN : 89.49 (+0.97%)
3 Under-the-Radar Biotech Stocks to Buy in 2023

These three lesser-known biotech companies are profitable and growing revenue.

AMLX : 1.9800 (+5.88%)
BMRN : 89.49 (+0.97%)
EXEL : 22.87 (+1.55%)
BioMarin to Host Third-Quarter 2023 Financial Results Conference Call and Webcast on Wednesday, November 1, at 4:30pm ET

/PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will...

BMRN : 89.49 (+0.97%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

BioMarin Pharmaceutical Inc. focuses on the development and commercialization of treatments for serious life-threatening medical conditions, mostly for children. The company's portfolio comprises seven marketed products namely, Aldurazyme, Naglazyme, Kuvan a rare genetic enzyme deficiency disorder),...

See More

Key Turning Points

3rd Resistance Point 90.82
2nd Resistance Point 90.31
1st Resistance Point 89.90
Last Price 89.49
1st Support Level 88.98
2nd Support Level 88.48
3rd Support Level 88.07

See More

52-Week High 99.56
Fibonacci 61.8% 90.57
Last Price 89.49
Fibonacci 50% 87.79
Fibonacci 38.2% 85.01
52-Week Low 76.02

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar